Felbamate
Felbamate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Felbamate; Generic name: FELBAMATE; Drug class: Anti-epileptic Agent [EPC].
| Brand name | Felbamate |
|---|---|
| Generic name | FELBAMATE |
| Drug class | Anti-epileptic Agent [EPC] |
| Manufacturer | ANI Pharmaceuticals, Inc. |
| Used for | INDICATIONS AND USAGE Felbamate Tablets USP are not indicated as a first line antiepileptic treatment (see WARNINGS ). Felbamate Tablets USP are recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use. If these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgement, Felbamate Tablets USP can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilep |
| Dosage | DOSAGE AND ADMINISTRATION Felbamate tablets have been studied as monotherapy and adjunctive therapy in adults and as adjunctive therapy in children with seizures associated with Lennox-Gastaut syndrome. As felbamate tablets are added to or substituted for existing AEDs, it is strongly recommended to reduce the dosage of those AEDs in the range of 20 to 33% to minimize side effects (see Drug Interactions subsection). Dosage Adjustment in the Renally Impaired: Felbamate should be used with caution |
| Warnings | WARNINGS See Boxed Warning regarding aplastic anemia and hepatic failure. Antiepileptic drugs should not be suddenly discontinued because of the possibility of increasing seizure frequency. Suicidal Behavior and Ideation Antiepileptic drugs (AEDs) including felbamate, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Patients treated with any AED for any indication should be monitored for the emergence or worsening of depression, suicidal thoug |
| Active ingredient(s) | FELBAMATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17850520-f823-4d05-8f9b-5eadfa68bae2 |